COVID-19 Vaccine: DCGI Grants Emergency Use Authorisation to ZycovD for Above 12-Year-Olds, Corbevax for Children Aged 5–12
The DCGI also gave restricted emergency use authorisation to Bharat Biotech's Covaxin for children between the age of 6-12 years.
- Read in
- বাংলা
The Drugs Controller General of India (DCGI) on Tuesday granted emergency use authorisation to ZycovD (Zydus Cadila vaccine) for children above the age of 12 years for a two-dose regimen, sources said. It has also granted emergency use authorisation to Corbevax for children between the age of 5-12 years. Earlier in the day, the DCGI gave restricted emergency use authorisation to Bharat Biotech's Covaxin.
Check tweet:
#COVID19 | DCGI also grants emergency use authorisation to ZycovD (Zydus Cadila vaccine) for children above the age of 12 years for a two-dose regimen: Sources
— ANI (@ANI) April 26, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on Apr 26, 2022 01:38 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
